Abstract:Cardiovascular diseases (CVDs) present a significant threat to health, with traditional therapeutics based treatment being hindered by inefficiencies, limited biological effects, and resistance to conventional drug. Addressing these challenges requires advanced approaches for early disease diagnosis and therapy. Nanotechnology and nanomedicine have emerged as promising avenues for personalized CVD diagnosis and treatment through theranostic agents. Nanoparticles serve as nanodevices or nanocarriers, efficiently transporting drugs to injury sites. These nanocarriers offer the potential for precise drug and gene delivery, overcoming issues like bioavailability and solubility. By attaching specific target molecules to nanoparticle surfaces, controlled drug release to targeted areas becomes feasible. In the field of cardiology, nanoplatforms have gained popularity due to their attributes, such as passive or active targeting of cardiac tissues, enhanced sensitivity and specificity, and easy penetration into heart and artery tissues due to their small size. However, concerns persist about the immunogenicity and cytotoxicity of nanomaterials, necessitating careful consideration. Nanoparticles also hold promise for CVD diagnosis and imaging, enabling straightforward diagnostic procedures and real-time tracking during therapy. Nanotechnology has revolutionized cardiovascular imaging, yielding multimodal and multifunctional vehicles that outperform traditional methods. The paper provides an overview of nanomaterial delivery routes, targeting techniques, and recent advances in treating, diagnosing, and engineering tissues for CVDs. It also discusses the future potential of nanomaterials in CVDs, including theranostics, aiming to enhance cardiovascular treatment in clinical practice. Ultimately, refining nanocarriers and delivery methods has the potential to enhance treatment effectiveness, minimize side effects, and improve patients' well-being and outcomes.

Nano- and Microparticle-based Imaging of Cardiovascular Interventions: Overview

Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes

Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities

Advances on interventional molecular imaging

Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics

Nanotechnology for cardiovascular diseases

Recent advances in nanomaterial-driven strategies for diagnosis and therapy of vascular anomalies

Intravascular MR Imaging and Intravascular MR-guided Interventions.

Interventional molecular imaging.

Intravascular Imaging of Atherosclerosis by Using Engineered Nanoparticles

Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.

Nanotechnology translation in vascular diseases: From design to the bench

Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease

In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development

Nanoparticle Therapy for Vascular Diseases

Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications

Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering

Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases

Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis

Modern micro and nanoparticle-based imaging techniques